Annual ophthalmologic monitoring would save 2 / 3 of them ...
Every five seconds one person loses his sight
while 270 million people have impaired orasi.Symfona with
estimates, blindness threaten 2020 75 million people around
the world, of which 2 / 3 could have prevented the
loss if submitting an annual eye tests. To limit the number of blind the International Commission for the Prevention of Blindness in collaboration with the World Health implement the program "2020: The Right to Sight." Nowadays the main causes of sight loss are vascular eye diseases (diabetic retinopathy, age-related macular, retinal thrombosis) and glaucoma. Diabetic retinopathy is a serious complication of diabetes mellitus. In our country estimated to have diabetes and one million people, approximately 10% of the population. At least 50% of diabetic persons not aware that he is suffering from the disease. "Diabetic retinopathy, occurs at a rate of 50 - 70% of diabetic patients after 15 years of disease and has a direct consequence of the severe vision impairment. This is characterized by doctors as one of the great tragedies of modern ophthalmology, " says Professor of Ophthalmology at the Aristotle University of Thessaloniki, Panayiotis Economides. The number of patients with diabetic retinopathy worldwide in 2000 was 4.1 million, while 2020 is estimated to reach 6.1 million. "The only treatment of diabetic retinopathy until recently was the early treatment-ray Laser. Today the use of antiangeiogenetikon agents and cortisone, which granted within the eye, offer the unique possibility of prevention of the complications , which lead to blindness. The antiangiogenic agents pegkaptanimpi ranimpizoumampi and were approved by the FDA (Agency for Food and Drug Administration of America). The preparation ranimpizoumampi is most commonly used drug, the use of which in Europe, adopted in 2007. If treatment starts early, vision stabilizes and slows down the development. The results of these studies were encouraging for the use of ranimpizoumampis not only to prevent loss of vision, but also for the improvement, with positive repercussions for the implementation of daily activities of patient and general quality of life, "adds Mr. Economides . Please note that the university clinic of AHEPA is ongoing genetic analysis of the Thessaloniki Eye Study, led by Associate Professor Fotis Topouzi, which aims to reveal genetic markers that correlate with an increased risk of developing various stages of age-related macula degeneration. The age-related macular degeneration affects people over 60 years and is the leading cause of blindness in old age in societies of the western world. In Greece with a population of 2.5 million people over 60 years, 35,000 people live in an attack in and 7,500 people to attack in both eyes, of which more than half do not know the cause of the blindness. "Individuals affected, but not blindly, lacking a relatively young age for the remainder of his life pleasures, like reading and watching, hobbies and enjoyable activities not recognize the faces of friends and relatives and then do not respond with dignity to their vital needs as their daily shopping, cooking, recognition of food on the plate, personal and household cleanliness. The macula is not a disease, as many believe, is an area that may be affected by many different diseases. One of them is the age-related macular degeneration, "says Professor of Ophthalmology at the Aristotle University of Thessaloniki, Stavros Dimitrakos. The age-related macular degeneration is a change due to age. It is the atrophy of the deep tunics of the eye and stopping the operation for which they were intended. This form of age- related macular degeneration, known as dry age-related macular degeneration, and so far has not found a treatment for treatment. In prevention may help eating fatty fish such as sardines and vegetables such as broccoli and spinach, and perhaps damaging smoke. Sometimes the dry form of age-related macular be expected that a slowly or suddenly in liquid form and because abnormal blood vessels grow in the degenerate region of the macula. The treatment of the disease at this stage is a good prospect for the preservation of valuable central vision. "Only the liquid form and is subject to certain conditions, can be curbed and no time to heal completely. Both are currently approved by the EMEA for intraocular drug use, and pegkaptanimpi ranimpizoumampi that despite their high cost, freely available to insured patients. In a multicenter international studies have shown that both inhibit the loss of visual acuity due to wet age-related macular degeneration " concludes Mr. Dimitrakos.
0 comments:
Post a Comment